Acetylcysteine solution is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Acetylcysteine solution is contraindicated in those patients who are sensitive to it
While GLP-1 was originally FDA-approved for type 2 diabetes, its effectiveness in weight loss has led many healthcare providers to consider it for non-diabetic patients
Following an Iron Infusion there can be a range of reactions anywhere from immediately after the IV up to 4 days after: including but not limited to: urticaria, rashes, joint swelling, joint pain, fever, flu-like symptoms, abdominal pain, diarrhea and constipation as well as muscle pain and cramping
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Aoki H., Furuya Y., Endo Y., Fujimoto K